| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Cytokinetics, Incorporated (CYTK) have been net sellers, shedding 191,426 shares worth roughly $13.5M on balance. In the past 30 days, 0 insiders bought and 2 sold.
Not all activity pointed one way: 2 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), CYTK's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 278.5K | $17.51M | -15,000 | |
| VP | 157.4K | $1.23M | -10,500 | |
| Dir | 78.7K | $5.03M | - | |
| VP | 68.6K | $1.59M | - | |
| Dir | 35.7K | $2.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 20, 2026 | Malik Fady Ibraham54 | EVP Research &Development | Sale+OE | 3,500 | $64.01 | $224,035.00 | -2.2% | |
| Oct 12, 2026 | Blum Robert I50 | President &CEO | Sale+OE | 7,500 | $62.88 | $471,600.00 | -2.6% | |
| Oct 6, 2026 | Malik Fady Ibraham54 | EVP Research &Development | Sale+OE | 3,500 | $61.38 | $214,830.00 | -2.2% | |
| Sep 28, 2026 | Blum Robert I50 | President &CEO | Sale+OE | 7,500 | $65.46 | $490,950.00 | -2.6% | |
| Sep 22, 2026 | Malik Fady Ibraham54 | EVP Research &Development | Sale+OE | 3,500 | $68.29 | $239,015.00 | -2.2% | |
| Sep 15, 2026 | Landry Robert E52 | Director | Sell | 1,000 | $72.13 | $72,130.00 | -10.9% | |
| Sep 15, 2026 | Blum Robert I50 | President &CEO | Sale+OE | 105,426 | $69.62 | $7,340,009.58 | -100% | |
| Sep 11, 2026 | Landry Robert E52 | Director | Sell | 1,000 | $74.66 | $74,660.00 | -9.8% | |
| Sep 8, 2026 | Malik Fady Ibraham54 | EVP Research &Development | Sale+OE | 3,500 | $75.46 | $264,110.00 | -2.2% | |
| Sep 1, 2026 | Parshall B Lynne74 | Director | Sell | 5,000 | $71.48 | $357,400.00 | -31.7% |